Global Breast Cancer Diagnostic and Drug Technologies Market Growth (Status and Outlook) 2024-2030

2024

Global Breast Cancer Diagnostic and Drug Technologies Market Growth (Status and Outlook) 2024-2030

Name: Global Breast Cancer Diagnostic and Drug Technologies Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001216
Price: 3450 USD
Availability: InStock
Rating: 4 (11.4 reviews)

The global Breast Cancer Diagnostic and Drug Technologies market was valued at US$ 15.7 billion in 2024, with rising demand in cancer diagnostics and treatment.

Bonafide Trust
20-09-2024
Pages : 85
Figures : 81
Tables : 96
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global breast cancer diagnostic and drug technologies market has witnessed substantial growth, driven by the increasing prevalence of breast cancer globally and advancements in medical technologies. Breast cancer remains one of the most common types of cancer, with a growing number of cases diagnosed each year, particularly in developed countries. This rise in cases has spurred greater demand for early detection and more effective treatments, which has consequently led to significant innovations in diagnostic tools and drug therapies. The market is further fueled by the increasing awareness of breast cancer and the rising healthcare expenditure in many regions, which has enabled greater access to advanced diagnostic technologies and treatment options. Breast cancer diagnostics encompass a wide range of technologies, including imaging techniques like mammography, ultrasound, and magnetic resonance imaging (MRI), as well as advanced methods such as biopsy and liquid biopsy for genetic testing. The increasing adoption of these technologies, coupled with the growing need for personalized and targeted treatments, has created a thriving market for breast cancer diagnostic tools and therapeutic drugs. Furthermore, the growing investment in research and development in both the pharmaceutical and biotechnology industries has accelerated the development of novel therapies, including immunotherapies, targeted therapies, and hormone therapies. These advances are revolutionizing the way breast cancer is diagnosed and treated, improving patient outcomes and offering hope for more effective management of the disease. As a result, the global breast cancer diagnostic and drug technologies market is experiencing rapid growth, driven by a combination of technological advancements, increased awareness, and ongoing research into more effective treatments.

According to Publisher, the global Breast Cancer Diagnostic and Drug Technologies market size was valued at US$ 15700 million in 2024. With growing demand in downstream market, the Breast Cancer Diagnostic and Drug Technologies is forecast to a readjusted size of US$ 18130 million by 2030 with a CAGR of 2.1% during review period. The demand for breast cancer diagnostics and drug technologies is further driven by the increasing focus on early detection, which has been shown to significantly improve survival rates. Early detection methods, including mammography and MRI, allow for the identification of tumors at smaller, more treatable stages, resulting in less aggressive treatments and improved prognosis for patients. In addition to conventional imaging techniques, newer, non-invasive methods such as digital mammography, breast ultrasound, and tomosynthesis are gaining popularity, offering higher accuracy in detecting cancerous cells, particularly in women with dense breast tissue. Liquid biopsy, a relatively new technology, is also emerging as a promising tool for detecting breast cancer at an early stage through the analysis of blood samples, providing a less invasive and faster alternative to traditional biopsy procedures. As diagnostic technologies continue to evolve, there is an increasing emphasis on integrating artificial intelligence (AI) and machine learning algorithms into imaging systems, allowing for faster and more accurate detection of abnormalities. This growing sophistication in diagnostic methods has led to improved patient care and reduced healthcare costs by enabling early intervention and better-targeted treatments. Moreover, the rise of personalized medicine has spurred the development of drug technologies aimed at targeting specific cancer cells and minimizing side effects. Therapies like targeted drugs, immunotherapies, and monoclonal antibodies have been gaining traction due to their ability to offer more precise treatment options, improving survival rates and enhancing the quality of life for patients. As both diagnostic and drug technologies continue to evolve, the market is expected to expand further, driven by the demand for better, more effective solutions for breast cancer detection and treatment.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The global breast cancer diagnostic and drug technologies market is segmented by diagnostic techniques and drug types, each addressing specific needs in the early detection and treatment of breast cancer. Diagnostic technologies include imaging methods such as mammography, ultrasound, MRI, and computed tomography (CT) scans, as well as biopsy procedures and genetic testing. Mammography, which uses low-dose X-rays to detect abnormalities in the breast tissue, remains the gold standard for routine breast cancer screening, especially in women over the age of 40. Ultrasound and MRI are often used in conjunction with mammography to further investigate abnormalities, particularly in dense breast tissue, while CT scans are employed in more advanced cases to detect metastasis. Biopsy procedures, including core needle biopsy and fine needle aspiration, are used to obtain tissue samples for histopathological examination to confirm the presence of cancer. Liquid biopsy, a cutting-edge technology, allows for non-invasive detection of genetic mutations and alterations in the blood, offering a promising approach for early detection and monitoring of breast cancer. On the drug side, the market is divided into several categories, including chemotherapy, hormone therapy, targeted therapy, immunotherapy, and biosimilars. Chemotherapy remains a cornerstone in breast cancer treatment, used in both early and advanced stages to target rapidly dividing cancer cells. Hormone therapy, which blocks or lowers estrogen levels, is effective in treating hormone receptor-positive breast cancers. Targeted therapies, such as HER2 inhibitors, are designed to specifically target cancer cells with certain genetic mutations, improving efficacy and reducing side effects. Immunotherapies, including checkpoint inhibitors and monoclonal antibodies, are an emerging class of treatments that enhance the body’s immune response to fight cancer cells. Biosimilars, which are biologic products highly similar to approved reference biologics, are expected to play a significant role in expanding treatment options for breast cancer patients. The continued development of new diagnostic and drug technologies in these segments will drive market growth, offering improved survival rates and a better quality of life for breast cancer patients.

The breast cancer diagnostic and drug technologies market is also segmented by application, with significant demand from hospitals, diagnostic centers, research institutions, and home care settings. Hospitals and diagnostic centers are the primary settings for breast cancer diagnostic tests, as they are equipped with advanced imaging technologies and laboratories capable of conducting biopsies and genetic testing. These centers play a crucial role in the early detection of breast cancer and in providing patients with personalized treatment plans based on the diagnosis. Research institutions are also key contributors to the market, with ongoing clinical trials and research initiatives focused on developing innovative diagnostic tools and drug therapies. These institutions are working on improving the accuracy of early detection methods and creating more effective, less invasive treatments for breast cancer. The rise of home care settings has also contributed to the market's expansion, with the availability of at-home testing kits for breast cancer detection, as well as the growing interest in telemedicine for consultation and follow-up care. These home care solutions are particularly valuable for individuals living in remote areas or those with limited access to healthcare facilities. Additionally, the demand for breast cancer drug therapies in hospitals and oncology centers is growing, as these institutions are at the forefront of providing cutting-edge treatments to patients. As awareness of breast cancer continues to rise globally and as healthcare infrastructure improves, the market for breast cancer diagnostics and drug technologies is expected to continue to expand, driven by demand from both developed and emerging economies. This growth is further supported by an increasing focus on early diagnosis, personalized treatment, and improved patient care, all of which are essential components in the fight against breast cancer.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size 2019-2030
2.1.2 Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Breast Cancer Diagnostic and Drug Technologies Segment by Type
2.2.1 Mammography
2.2.2 Biopsy
2.2.3 Other
2.3 Breast Cancer Diagnostic and Drug Technologies Market Size by Type
2.3.1 Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2019-2024)
2.4 Breast Cancer Diagnostic and Drug Technologies Segment by Application
2.4.1 Ductal Carcinoma of Breast
2.4.2 Invasive Ductal Carcinoma
2.4.3 Lobular Carcinoma
2.4.4 Triple Negative Breast Cancer
2.5 Breast Cancer Diagnostic and Drug Technologies Market Size by Application
2.5.1 Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2019-2024)
3 Breast Cancer Diagnostic and Drug Technologies Market Size by Player
3.1 Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Players
3.1.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue by Players (2019-2024)
3.1.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Breast Cancer Diagnostic and Drug Technologies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Breast Cancer Diagnostic and Drug Technologies by Regions
4.1 Breast Cancer Diagnostic and Drug Technologies Market Size by Regions (2019-2024)
4.2 Americas Breast Cancer Diagnostic and Drug Technologies Market Size Growth (2019-2024)
4.3 APAC Breast Cancer Diagnostic and Drug Technologies Market Size Growth (2019-2024)
4.4 Europe Breast Cancer Diagnostic and Drug Technologies Market Size Growth (2019-2024)
4.5 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Growth (2019-2024)
5 Americas
5.1 Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024)
5.2 Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024)
5.3 Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2019-2024)
6.2 APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024)
6.3 APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Breast Cancer Diagnostic and Drug Technologies by Country (2019-2024)
7.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024)
7.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies by Region (2019-2024)
8.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024)
8.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.1 Global Breast Cancer Diagnostic and Drug Technologies Forecast by Regions (2025-2030)
10.1.1 Global Breast Cancer Diagnostic and Drug Technologies Forecast by Regions (2025-2030)
10.1.2 Americas Breast Cancer Diagnostic and Drug Technologies Forecast
10.1.3 APAC Breast Cancer Diagnostic and Drug Technologies Forecast
10.1.4 Europe Breast Cancer Diagnostic and Drug Technologies Forecast
10.1.5 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Forecast
10.2 Americas Breast Cancer Diagnostic and Drug Technologies Forecast by Country (2025-2030)
10.2.1 United States Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.2.2 Canada Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.2.3 Mexico Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.2.4 Brazil Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.3 APAC Breast Cancer Diagnostic and Drug Technologies Forecast by Region (2025-2030)
10.3.1 China Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.3.2 Japan Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.3.3 Korea Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.3.4 Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.3.5 India Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.3.6 Australia Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.4 Europe Breast Cancer Diagnostic and Drug Technologies Forecast by Country (2025-2030)
10.4.1 Germany Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.4.2 France Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.4.3 UK Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.4.4 Italy Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.4.5 Russia Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.5 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Forecast by Region (2025-2030)
10.5.1 Egypt Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.5.2 South Africa Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.5.3 Israel Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.5.4 Turkey Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.5.5 GCC Countries Breast Cancer Diagnostic and Drug Technologies Market Forecast
10.6 Global Breast Cancer Diagnostic and Drug Technologies Forecast by Type (2025-2030)
10.7 Global Breast Cancer Diagnostic and Drug Technologies Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Breast Cancer Diagnostic and Drug Technologies Product Offered
11.1.3 Abbott Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Breast Cancer Diagnostic and Drug Technologies Product Offered
11.2.3 Roche Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 BioMerieux
11.3.1 BioMerieux Company Information
11.3.2 BioMerieux Breast Cancer Diagnostic and Drug Technologies Product Offered
11.3.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 BioMerieux Main Business Overview
11.3.5 BioMerieux Latest Developments
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Information
11.4.2 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product Offered
11.4.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Becton Dickinson Main Business Overview
11.4.5 Becton Dickinson Latest Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Information
11.5.2 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product Offered
11.5.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GE Healthcare Main Business Overview
11.5.5 GE Healthcare Latest Developments
11.6 Hologic
11.6.1 Hologic Company Information
11.6.2 Hologic Breast Cancer Diagnostic and Drug Technologies Product Offered
11.6.3 Hologic Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Hologic Main Business Overview
11.6.5 Hologic Latest Developments
11.7 Philips
11.7.1 Philips Company Information
11.7.2 Philips Breast Cancer Diagnostic and Drug Technologies Product Offered
11.7.3 Philips Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Philips Main Business Overview
11.7.5 Philips Latest Developments
11.8 PerkinElmer
11.8.1 PerkinElmer Company Information
11.8.2 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product Offered
11.8.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 PerkinElmer Main Business Overview
11.8.5 PerkinElmer Latest Developments
11.9 Quest Diagnostics
11.9.1 Quest Diagnostics Company Information
11.9.2 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product Offered
11.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Quest Diagnostics Main Business Overview
11.9.5 Quest Diagnostics Latest Developments
12 Research Findings and Conclusion

Table 1. Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Mammography
Table 3. Major Players of Biopsy
Table 4. Major Players of Other
Table 5. Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2019-2024)
Table 8. Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2019-2024)
Table 11. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Player (2019-2024)
Table 13. Breast Cancer Diagnostic and Drug Technologies Key Players Head office and Products Offered
Table 14. Breast Cancer Diagnostic and Drug Technologies Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Regions (2019-2024)
Table 19. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Country (2019-2024)
Table 23. Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2019-2024)
Table 25. Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2019-2024)
Table 27. APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Region (2019-2024)
Table 29. APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2019-2024)
Table 31. APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2019-2024)
Table 33. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Country (2019-2024)
Table 35. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2019-2024)
Table 37. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Breast Cancer Diagnostic and Drug Technologies
Table 46. Key Market Challenges & Risks of Breast Cancer Diagnostic and Drug Technologies
Table 47. Key Industry Trends of Breast Cancer Diagnostic and Drug Technologies
Table 48. Global Breast Cancer Diagnostic and Drug Technologies Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Breast Cancer Diagnostic and Drug Technologies Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Breast Cancer Diagnostic and Drug Technologies Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Abbott Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 53. Abbott Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 54. Abbott Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Abbott Main Business
Table 56. Abbott Latest Developments
Table 57. Roche Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 58. Roche Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 59. Roche Main Business
Table 60. Roche Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Roche Latest Developments
Table 62. BioMerieux Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 63. BioMerieux Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 64. BioMerieux Main Business
Table 65. BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. BioMerieux Latest Developments
Table 67. Becton Dickinson Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 68. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 69. Becton Dickinson Main Business
Table 70. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Becton Dickinson Latest Developments
Table 72. GE Healthcare Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 73. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 74. GE Healthcare Main Business
Table 75. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. GE Healthcare Latest Developments
Table 77. Hologic Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 78. Hologic Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 79. Hologic Main Business
Table 80. Hologic Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Hologic Latest Developments
Table 82. Philips Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 83. Philips Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 84. Philips Main Business
Table 85. Philips Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Philips Latest Developments
Table 87. PerkinElmer Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 88. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 89. PerkinElmer Main Business
Table 90. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. PerkinElmer Latest Developments
Table 92. Quest Diagnostics Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 93. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 94. Quest Diagnostics Main Business
Table 95. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Quest Diagnostics Latest Developments
List of

Figure 1. Breast Cancer Diagnostic and Drug Technologies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Breast Cancer Diagnostic and Drug Technologies Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Country/Region (2023)
Figure 8. Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type in 2023
Figure 10. Breast Cancer Diagnostic and Drug Technologies in Ductal Carcinoma of Breast
Figure 11. Global Breast Cancer Diagnostic and Drug Technologies Market: Ductal Carcinoma of Breast (2019-2024) & ($ Millions)
Figure 12. Breast Cancer Diagnostic and Drug Technologies in Invasive Ductal Carcinoma
Figure 13. Global Breast Cancer Diagnostic and Drug Technologies Market: Invasive Ductal Carcinoma (2019-2024) & ($ Millions)
Figure 14. Breast Cancer Diagnostic and Drug Technologies in Lobular Carcinoma
Figure 15. Global Breast Cancer Diagnostic and Drug Technologies Market: Lobular Carcinoma (2019-2024) & ($ Millions)
Figure 16. Breast Cancer Diagnostic and Drug Technologies in Triple Negative Breast Cancer
Figure 17. Global Breast Cancer Diagnostic and Drug Technologies Market: Triple Negative Breast Cancer (2019-2024) & ($ Millions)
Figure 18. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application in 2023
Figure 19. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Player in 2023
Figure 20. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Breast Cancer Diagnostic and Drug Technologies Market Size 2019-2024 ($ Millions)
Figure 22. APAC Breast Cancer Diagnostic and Drug Technologies Market Size 2019-2024 ($ Millions)
Figure 23. Europe Breast Cancer Diagnostic and Drug Technologies Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size 2019-2024 ($ Millions)
Figure 25. Americas Breast Cancer Diagnostic and Drug Technologies Value Market Share by Country in 2023
Figure 26. United States Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Region in 2023
Figure 31. APAC Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type in 2023
Figure 32. APAC Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application in 2023
Figure 33. China Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Country in 2023
Figure 40. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2019-2024)
Figure 41. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2019-2024)
Figure 42. Germany Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 56. APAC Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 57. Europe Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 59. United States Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 60. Canada Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 63. China Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 64. Japan Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 65. Korea Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 67. India Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 68. Australia Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 69. Germany Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 70. France Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 71. UK Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 72. Italy Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 73. Russia Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 74. Spain Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 77. Israel Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Breast Cancer Diagnostic and Drug Technologies Market Size 2025-2030 ($ Millions)
Figure 80. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted